Executive Director, Microbiology Quality Sterility Assurance

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more:

The Executive Director, Microbiology Quality Sterility Assurance (MQSA) is a pivotal global leadership role within BMS’s Corporate Quality organization. This position brings critical expertise in sterility assurance, microbiological controls, and contamination control strategy across BMS’s internal and external commercial and PD manufacturing sites — spanning pharmaceutical, biopharmaceutical, cell therapy and radiopharmaceuticals. This role is responsible for defining, owning, and governing BMS’s enterprise-wide Contamination Control Strategy (CCS) as a living, risk-based framework — ensuring alignment with EU GMP Annex 1, FDA, and all applicable global regulatory standards.
The Executive Director serves as the global Single Point of Contact (SPOC) for all sterility assurance and microbiology quality matters, partnering with Product Development (PD), Materials Science & Technology (MSAT), Quality, Internal Manufacturing, and External Manufacturing (EXM) to ensure the highest standards of microbiological control are embedded across BMS’s manufacturing network.
This is a highly strategic and visible role, operating at the intersection of technical excellence, regulatory compliance, contamination control governance, business planning, and people leadership — with significant influence at the senior executive level.
The Executive Director is expected to build and lead this newly established central function, establishing it as a center of excellence for CCS and sterility assurance across BMS’s global network.

• Define, own, and drive BMS’s Global Sterility & Microbiology Assurance Strategy, ensuring alignment across all manufacturing sites, CMOs, MS&T, GTS and PD partners
• Serve as the primary executive-level contact for contamination control and sterility assurance across Operations, Engineering, MS&T, and PD
• Embed control contamination and aseptic assurance strategy and aseptic-by-design principles into future processes and product development programs
• Lead remediation plans following regulatory observations, ensuring proactive installation of appropriate aseptic assurance standards (QMS and standard work) across the business
• Champion continuous improvement initiatives including KPI trending and capability development in aseptic and sterility assurance domains and process confirmations
• Own and periodically review BMS’s Global CCS as a living document, ensuring it reflects current regulatory requirements
• Establish, own, and govern BMS’s global sterility/aseptic assurance and CCS performance metrics framework, including KPI definitions, network-level escalation thresholds, trend analysis, and executive-level reporting cadence

• Support any implementation of BMS’s Sterility Assurance Strategy
• Lead CMO support in establishing and executing annual Contamination Control Strategies (CCS) and Aseptic/Sterility Assurance Roadmaps
• Partner with CMOs for KPI analysis, trending, escalation, and gap assessments versus BMS standards (GQPs, QMS, FDA Guidance, etc.)
• Conduct due diligence activities during onboarding of new CMOs.
• Drive alignment in ways of working and standard operating procedures between all CMO partners in aseptic/sterility…